Long Term Safety Protocol for the AcrySof CACHET Phakic Lens

Completed · Not applicable

Conditions studied: Myopia

In brief

The purpose of this long term safety study is to estimate the annualized endothelial cell loss (ECL) rate (for up to 10 years following date of implantation) of subjects previously implanted with the ACRYSOF CACHET Phakic Intraocular Lens (L-series) from precursor clinical studies C-02-23, C-02-40, C-03-21 and C-05-57.

Key facts

Study ID

NCT01497067

Run by

Alcon Research

People needed

657

Starts

2011-11-21

Expected to finish

2018-06-15

Last updated by the study team

2019-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Previously implanted with an ACRYSOF CACHET Phakic Lens (L-Series) from clinical studies C-02-23, C-02-40, C-03-21 and C-05-57 and eligible for continued follow-up (i.e., exited from the previous study).
• Able to understand and sign a statement of informed consent.
• Willing and able to complete the yearly postoperative study visits.

You may not qualify if…

• None

Where it is running

• Contact Alcon Call Center for Trial Locations — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.